Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -27.28%310.03M | -19.99%297.76M | -54.18%218.19M | -35.16%1.65B | -46.44%370.72M | -15.37%426.34M | -37.91%372.16M | -35.84%476.2M | -20.83%2.54B | -17.00%692.16M |
| Cost of revenue | -37.69%1.38B | -20.01%2.21B | ||||||||
| Gross profit | -18.22%270.33M | -25.88%330.54M | ||||||||
| Operating expense | -33.11%264.07M | -9.71%270.86M | -56.57%189.2M | -21.06%219.84M | -42.21%341.93M | -13.70%394.78M | -46.38%299.98M | -37.25%435.69M | 9.20%278.5M | 130.64%591.72M |
| Selling and administrative expenses | ---- | ---- | ---- | -18.23%169.37M | ---- | ---- | ---- | ---- | 4.57%207.13M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 13.44%36.69M | ---- | ---- | ---- | ---- | 5.33%32.35M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -24.09%132.67M | ---- | ---- | ---- | ---- | 4.43%174.78M | ---- |
| Other operating expenses | -26.17%304.1M | -8.65%287.58M | -50.21%222.03M | -29.29%50.47M | -52.26%360.09M | -11.83%411.9M | -44.69%314.79M | -36.84%445.91M | 25.32%71.37M | 134.75%754.27M |
| Total other operating income | 133.75%40.03M | 12.88%16.72M | 221.30%32.83M | -68.86%60.31M | -88.83%18.16M | 75.76%17.12M | 52.60%14.81M | -12.55%10.22M | --193.68M | --162.55M |
| Operating profit | 45.59%45.95M | -62.73%26.9M | -28.43%28.99M | -2.99%50.49M | -71.33%28.8M | -31.84%31.56M | 80.90%72.17M | -15.49%40.51M | -72.74%52.05M | 1,537.41%100.44M |
| Net non-operating interest income (expenses) | 18.28%-26.04M | -2.82%-27.7M | -14.92%-27.44M | 8.91%-82.09M | -1.00%-26.14M | -5.61%-31.86M | 6.67%-26.94M | 14.26%-23.88M | -11.61%-90.12M | -194.29%-25.88M |
| Non-operating interest income | ---- | ---- | ---- | 5.46%21.97M | ---- | ---- | ---- | ---- | 17.41%20.83M | ---- |
| Non-operating interest expense | -18.28%26.04M | 2.82%27.7M | 14.92%27.44M | -2.62%35.56M | 1.00%26.14M | 5.61%31.86M | -6.67%26.94M | -14.26%23.88M | 14.07%36.51M | 164.79%25.88M |
| Total other finance cost | ---- | ---- | ---- | -7.97%68.5M | ---- | ---- | ---- | ---- | 11.97%74.44M | ---- |
| Net investment income | 149.85M | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -65.87%440K | -37.46%1.29M | ||||||||
| Income from associates and other participating interests | 38.61%3.64M | 30.05%4.06M | 41.83%3.31M | -13.01%10.82M | -47.03%2.74M | 3.47%2.62M | -26.75%3.13M | 395.33%2.33M | 123.51%12.44M | 183.99%5.16M |
| Special income (charges) | 655.18%62.19M | -178.31%-11.2M | ||||||||
| Less:Write off | ---- | ---- | ---- | -655.18%-62.19M | ---- | ---- | ---- | ---- | 185.11%11.2M | ---- |
| Other non-operating income (expenses) | 66.39%33.19M | -10.25%19.95M | ||||||||
| Income before tax | 911.38%23.56M | -93.25%3.27M | -74.40%4.85M | -44.10%75.04M | -93.23%5.39M | -87.53%2.33M | 216.09%48.36M | -7.75%18.96M | -13.01%134.25M | 111.21%79.73M |
| Income tax | 390.86%18.39M | -293.54%-11.51M | -123.42%-3.75M | -65.34%11.49M | 1,444.60%4.73M | -136.81%-6.32M | -166.91%-2.92M | 33.72%16.01M | -67.10%33.16M | -101.43%-352K |
| Net income | -40.27%5.17M | -71.19%14.77M | 191.43%8.6M | -37.14%63.55M | -99.17%661K | 476.73%8.65M | 369.23%51.28M | -65.59%2.95M | 88.78%101.09M | 510.76%80.08M |
| Net income continuous operations | -40.27%5.17M | -71.19%14.77M | 191.43%8.6M | -37.14%63.55M | -99.17%661K | 476.73%8.65M | 369.23%51.28M | -65.59%2.95M | 88.78%101.09M | 510.76%80.08M |
| Noncontrolling interests | 126.44%55K | -387.25%-293K | 126.00%13K | -325.45%-124K | 120.92%32K | -620.00%-208K | 67.21%102K | -146.73%-50K | 100.49%55K | -262.77%-153K |
| Net income attributable to the company | -42.30%5.11M | -70.56%15.07M | 186.14%8.59M | -36.98%63.67M | -99.22%629K | 506.78%8.86M | 370.92%51.18M | -64.57%3M | 55.80%101.03M | 516.35%80.23M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -42.30%5.11M | -70.56%15.07M | 186.14%8.59M | -36.98%63.67M | -99.22%629K | 506.78%8.86M | 370.92%51.18M | -64.57%3M | 55.80%101.03M | 516.35%80.23M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -45.00%0.0011 | -70.43%0.0034 | 171.43%0.0019 | -36.73%0.0143 | -99.44%0.0001 | 566.67%0.002 | -95.21%0.0115 | -63.16%0.0007 | 55.86%0.0226 | 520.69%0.018 |
| Diluted earnings per share | -45.00%0.0011 | -70.43%0.0034 | 171.43%0.0019 | -36.73%0.0143 | -99.44%0.0001 | 566.67%0.002 | -95.21%0.0115 | -63.16%0.0007 | 55.86%0.0226 | 520.69%0.018 |
| Dividend per share | 0 | 0.00%0.01 | 0 | 0.00%0.01 | 0 | 0 | 0.00%0.01 | 0 | 0.00%0.01 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.